82 related articles for article (PubMed ID: 3360102)
1. [Clinical and experimental validation of the use of the tranquilizer mebikar as a corrective of the neuroleptic syndrome].
Zimakova IE; Semenikhin DG; Karpov AM; Kirshin SV
Farmakol Toksikol; 1988; 51(1):21-3. PubMed ID: 3360102
[TBL] [Abstract][Full Text] [Related]
2. [Results of the experimental study and clinical use of the tranquilizer mebikar].
Kamburg RA; Zaikonnikova IV
Farmakol Toksikol; 1986; 49(2):89-91. PubMed ID: 3519278
[No Abstract] [Full Text] [Related]
3. [Mechanisms of the antishock action of mebikar].
Zimakova IE; Bazarevich GIa; Kamburg RA; Nizamutdinov EZ
Farmakol Toksikol; 1984; 47(2):28-32. PubMed ID: 6714398
[TBL] [Abstract][Full Text] [Related]
4. Neuroleptic malignant syndrome: a case report.
Fekadu A; Wakwoya A
Ethiop Med J; 1999 Jul; 37(3):195-8. PubMed ID: 11957317
[TBL] [Abstract][Full Text] [Related]
5. [Comparative analysis of the behavioral, neurochemical and autonomotropic effects of mebikar and diazepam].
Zimakova IE; Kirshin SV; Kamburg RA
Farmakol Toksikol; 1982; 45(5):23-6. PubMed ID: 6128252
[TBL] [Abstract][Full Text] [Related]
6. [Effect of mebikar on the experimental and clinical course of traumatic shock].
Bazarevich GIa; Zimakova IE; Kharin GM; Katkovskiĭ GB; Lazareva LV
Vestn Khir Im I I Grek; 1981 Jul; 127(7):81-5. PubMed ID: 7292861
[TBL] [Abstract][Full Text] [Related]
7. Morphine potentiates the impairing effects of neuroleptics on two-way active conditioned avoidance response in male mice.
Aguilar MA; Miñarro J; Simón VM
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):225-37. PubMed ID: 14751417
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the nootropic effect of mebikar in clinical practice].
Zimakova IE; Makarchikov NS; Karpov AM
Farmakol Toksikol; 1986; 49(5):50-3. PubMed ID: 3770177
[TBL] [Abstract][Full Text] [Related]
9. [Use of the tranquilizer mebikar for treating climacteric neuropsychic disorders].
Mendelevich DM; Zimakova IE; Mendelevich VD
Akush Ginekol (Mosk); 1983 Feb; (2):51-3. PubMed ID: 6846724
[No Abstract] [Full Text] [Related]
10. [The effect of neuroleptics of the phenothiazine series when introduced into the hippocampus on conditioned defense reflexes].
Liubimov BI
Farmakol Toksikol; 1972; 35(6):653-7. PubMed ID: 4651793
[No Abstract] [Full Text] [Related]
11. Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report.
Khan A; Jaffe JH; Nelson WH; Morrison B
J Clin Psychiatry; 1985 Jun; 46(6):244-6. PubMed ID: 3922961
[TBL] [Abstract][Full Text] [Related]
12. [Neuroleptic malignant syndrome].
Charra B; Nejmi H; Hachimi A; Benslama A; Motaouakkil S
Ann Fr Anesth Reanim; 2006 May; 25(5):542-3. PubMed ID: 16488105
[No Abstract] [Full Text] [Related]
13. [Effect of mebikar on the state of animals under extreme conditions].
Zimakova IE; Kamburg RA; Kirshin SV
Farmakol Toksikol; 1980; 43(4):368-71. PubMed ID: 7439369
[TBL] [Abstract][Full Text] [Related]
14. [Neuroleptic malignant syndrome--case report].
Rakus A; Kroczak M
Przegl Lek; 2001; 58(4):367-70. PubMed ID: 11450372
[TBL] [Abstract][Full Text] [Related]
15. [Effect of homotaurine on the learning and maintenance of the conditioned reflex of escape in the rat].
Giotti A
Boll Soc Ital Biol Sper; 1975 Nov; 51(22):1723-6. PubMed ID: 1230174
[No Abstract] [Full Text] [Related]
16. [Neuroleptic malignant syndrome. Case reports].
Berardi D; Troia M; Veronesi L; Ferrari G
Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
[TBL] [Abstract][Full Text] [Related]
17. [The neuroleptic malignant syndrome in an adolescent. Its treatment with dantrolene, bromocryptin and diazepam].
Real Rodríguez B; Ruibal JL; Grande Rodríguez S; Sueiro Pita B
An Esp Pediatr; 1996 Jan; 44(1):60-2. PubMed ID: 8849063
[No Abstract] [Full Text] [Related]
18. [Mebikar in climacteric myocardiodystrophy].
Zamotaev IP; Mkrtchian VR; Venediktova MG
Sov Med; 1987; (8):57-60. PubMed ID: 3423965
[No Abstract] [Full Text] [Related]
19. Therapy of neuroleptic malignant syndrome.
Lazarus A
Psychiatr Dev; 1986; 4(1):19-30. PubMed ID: 3703852
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
